SAN FRANCISCO, CA—In the 3-and-a-half years after the Watchman device (Boston Scientific) was approved for left atrial appendage (LAA) occlusion in high-risk patients with atrial fibrillation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback